SecBot SecBot

FBIO

Fortress Biotech, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001429260 Biotech & Drug Discovery
$1.87 −0.06 (−3.11%)
Oct 26 4:00 PM ET · prev $1.93
Market cap
$66.4M
Micro cap
Median target
$5.00
+167% · range $5.00–5.00
Next earnings
Nov 12
in 17 days · EPS est. −$0.27
1 year
−27.2%
from $2.57 · Oct 27
30 days
−13.8%
from $2.17
52-week range
$1.87–4.38
−57% from high · low Oct 16
Avg volume 20D
255.5K
shares / day
Short interest
4.90M
≈14.7% of shares · −4.1%
Days to cover
18.4
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read BULLISH 1 report · 90 days
Balance 0 bearish · 1 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 12, 2026
Strongest BULLISH Fortress Biotech repaid the remaining $15.0 million in outstanding principal under its Oaktree senior…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBEARISH

    Q2 2026: 2 added (0 new), 6 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.150 → −$0.270 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersSTEADY

    Short interest −4.1% to 4.90M shares. 18.4 days to cover, ≈14.7% of shares.

  • TrendDOWNTREND

    21% below its 50-day average. New closing low $1.87 on Oct 26.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CITADEL ADVISORS LLCTRIM77,065$235.8K
NORTHERN TRUST CORPTRIM63,632$194.7K
UBS Group AGDOUBLED52,346$160.2K
SUSQUEHANNA INTERNATIONAL GROUP, LLPNEAR_EXIT47,002$143.8K
JANE STREET GROUP, LLCTRIM25,414$77.8K
SIMPLEX TRADING, LLCNEAR_EXIT14,508$44.4K
OSAIC HOLDINGS, INC.ADD9,061$27.7K
WELLS FARGO & COMPANY/MNTRIM5,000$15.3K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Feb 2026
12-month targets · 1 analysts

Price is below the lowest target. Median implies +167%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Feb 23, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Aug 21, 2025HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Mar 11, 2025Roth MKM
REITERATE
REITERATEBuy
Nov 18, 2024HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Jul 19, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy
Jun 20, 2024Cantor Fitzgerald
REITERATE
REITERATEOverweight

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Oct 1, 2026
Jin David
Chief Financial Officer
AWARD$2.2K
Jun 22, 2026
Jin David
Chief Financial Officer
AWARD400,000 sh
Apr 1, 2026
Jin David
Chief Financial Officer
AWARD$6.5K
Mar 18, 2026
WEISS MICHAEL S
Executive Vice Chairman
AWARD475,424 sh
Mar 18, 2026
ROSENWALD LINDSAY A MD
PRESIDENT, CEO & CHAIRMAN
AWARD475,424 sh

Earnings setup

Estimates
Nov 12
reports in 17 days
−$0.27
EPS estimate, this quarter
−80%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.27-$0.27–-$0.27-80.0%$21.6M
Next Q-$0.25-$0.25–-$0.25-78.6%$22.5M
Current FY$2.55$2.55–$2.55+6.2%$78.8M
Next FY-$1.00-$1.00–-$1.00-100.0%$113.3M

Short side

FINRA· Sep 30, 2026
4,898,052
shares short
-4.1%
vs prior settlement
18.4
days to cover
≈14.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 SEC
Fortress Biotech repaid the remaining $15.0 million in outstanding principal under its Oaktree senior secured credit…
8-K — Impact 5/10
Oct 1, 2026 Insider
Jin David was granted 1,190 shares
Chief Financial Officer @ $1.82 ($2.2K)
Sep 8, 2026 Other
Journey Medical Corporation to Participate in September 2026 Investor Conferences
SCOTTSDALE, Ariz., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”
Jun 30, 2026 Inst.
CITADEL ADVISORS LLC — TRIM
77,065 shares ($235.8K)
Jun 30, 2026 Inst.
NORTHERN TRUST CORP — TRIM
63,632 shares ($194.7K)
Jun 22, 2026 Insider
Jin David was granted 400,000 shares
Chief Financial Officer
May 18, 2026 SEC
Fortress Biotech announced CEO participation in a fireside chat at A.G.P.'s Virtual Healthcare Conference. The filing…
PRESS-RELEASE — Impact 2/10
May 4, 2026 SEC
Fortress Biotech announced CEO participation in a fireside chat at the H.C. Wainwright Royalty Conference. No…
PRESS-RELEASE — Impact 2/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
FBIO Q3 2026 Earnings Scheduled — 2026-11-12
Recent
Sep 8, 2026
Press release
Journey Medical Corporation to Participate in September 2026 Investor Conferences
SCOTTSDALE, Ariz., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage…
Sep 8, 2026
Earnings
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on…
Aug 12, 2026
Earnings
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Total revenues were $18.5 million for the second quarter of 2026, reflecting 23% growth from the prior-year quarter
Aug 12, 2026
Earnings date
FBIO Q2 2026 Earnings Scheduled — 2026-08-12
Aug 7, 2026
Press release
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Fortress Biotech, Inc. (NASDAQ: FBIO)
NEW YORK, Aug. 7, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Fortress Biotech, Inc. (NASDAQ: FBIO)…

SecBot reports

3 filings · 1 press release · 1 bullish · 0 bearish · 2 neutral
All FBIO filing & press-release reports (4)